MediBioSense VitalPatch technology utilised to pre-determine chronic inflammatory (flare-up) in patient with inflammatory bowel diseases (IBD), comprising Crohn disease and ulcerative colitis (UC). In this prospective study carried out at Mount Sinai Hospital, New York, longitudinally evaluated HRV was found to be associated with UC symptoms, inflammation, and perceived and physiological measures of stress. This […]
hereMediBioSense launch continuous ECG Cardiac monitoring utilising our VitalPatch technology. Detecting up to 21 real-time Arrhythmias with instant on-demand reporting/analysis. The future of Holter monitoring is here today. No more need to wear bulky uncomfortable holter’s with repeat trips to the doctor and extended waits for results. Today, analysis, results and detection happen in real-time […]
MediBioSense are proud to be announced the winner of the Digital Product of the Year at the UK Innovation and Technology 2020 Awards.
MediBioSense are honoured to be announced as a Export Champion 2020 – UK Gov (Dept. International Trade).
MediBioSense enable on demand AI enabled ECG cardiac reporting (medically certified).This is a game changer for our global clients to allow them to create instant ECG cardiac reports whilst remotely monitoring their patients. See more information Here
Coming Soon – MediBioSense unveil Bio-Pin. a magnetic health wearable that you can clip to clothing and detects body temp and activity in real-time
MediBioSense are honoured to be finalists for 3 technology innovation awards It a great recognition for the team and all their hard work
MediBioSense are pleased to announce enhanced VitalPatch now with 7 day use and body temperature receives CE Class IIa medical certification to accompany FDA approval.
MediBioSense release demo video of the AI technology they are working with that detects vital signs using in built camera phone found in mobile devices. This showcases the Future of Healthcare and Artificial Intelligence
MediBioSense are pleased to announce they are part of a successful consortium in receiving €42 million H2020 EU funding. MediBioSense will be providing healthcare wearable technologies as part of the project. The European research project is to Identify Digital Endpoints to Assess FAtigue, Sleep and acTivities of daily living (acronym: IDEA-FAST) in the following neurodegenerative […]